NFKB1 and rheumatoid arthritis: In a clinical trial on rheumatoid arthritis, Tol-DC were induced by Bay11-7082, the inhibitor of NF-κB, which irreversibly inhibited NF-κB by preventing phosphorylation of IκBa (58).